EGFR and cancer: In addition, several mechanisms of cancer development are related to ANO1, such as the EGFR-mediated AKT/SRC/ERK1/2 or Ras-Raf-MEK-ERK1/2 pathways; nonetheless, the underlying mechanism is unclear in NSCLC [8,13].